Vanguard Fiduciary Trust
STIM icon

Vanguard Fiduciary Trust’s Neuronetics STIM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
264,734
+6,700
+3% +$9.75K ﹤0.01% 3400
2026
Q1 		$374K Buy
+258,034
New +$409K ﹤0.01% 3306

Other funds holding STIM

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Vanguard Fiduciary Trust's STIM Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Neuronetics (STIM) stake by 2.6% in Q2 2026, buying an estimated $9.75K and bringing the position to 264,734 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #3400.

Vanguard Fiduciary Trust first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $374K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Vanguard Fiduciary Trust held 264,734 shares of Neuronetics worth $344K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 6,700 Neuronetics shares in Q2 2026, an estimated $9.75K.
  • Neuronetics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3400 holding.
  • Vanguard Fiduciary Trust first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Neuronetics position peaked at $374K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.